Clinical Trials in Nashville

Showing 5841-5860 of 20,298 trials

Technology Based Sedentary Reduction Intervention in Patients With Type 2 Diabetes

NCT05691452

The purpose of this study is to develop and test an 8-week sedentary behavior reduction intervention ("Sit Less" program) for patients with type 2 diabetes. The program aims to reduce and break sitting times among this population using an objective activity monitor and mHealth. The investigators will test the program to help diabetes patients break up sitting time, reduce daily sitting time, and move more. The investigators will also study preliminary effects of the SB reduction intervention on light physical activity, cardiometabolic markers and patient-centered outcomes, and whether diabetes patients like the program and can follow it.

Type 2 DiabetesSedentary BehaviorPhysical Activity

Vanderbilt University31 participantsStarted Jan 2023

Nashville, Tennessee, United States

COMPLETEDPhase 1< 1 mile

PF-06863135 As Single Agent And In Combination With Immunomodulatory Agents In Relapse/Refractory Multiple Myeloma

NCT03269136

To assess the safety and tolerability at increasing dose levels of PF-06863135 in patients with relapse/ refractory multiple myeloma in order to determine the maximum tolerated dose and select the recommended Phase 2 dose.

Multiple Myeloma

Pfizer101 participantsStarted Nov 2017

Encinitas, California, United States • La Jolla, California, United States • La Jolla, California, United States +34 more locations

Technology Based Sedentary Reduction Intervention in Patients With Type 2 Diabetes

PF-06863135 As Single Agent And In Combination With Immunomodulatory Agents In Relapse/Refractory Multiple Myeloma

Find Trials by Condition in Nashville

APR-246 & Azacitidine for the Treatment of TP53 Mutant Myelodysplastic Syndromes (MDS)

IMPROVE AKI Cluster-Randomized Trial

EVAS2 IDE Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study

Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors

A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes

A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases

A Study of Mavacamten in Participants With HFpEF and Elevation of NT-proBNP With or Without Elevation of cTnT

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders

Study of MK-6552 in Participants With Narcolepsy Type 1 (MK-6552-004)

Evaluation of Maralixibat in Biliary Atresia Response Post-Kasai

A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer

LOVE Trial: Limits On Vaginal Intercourse After Mid-urEthral Sling

Optical Coherence Tomography (OCT) Reference Data Collection Study (S-2015-3)

Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease

Study to Compare 2 Botulinum Type A Toxins in the Treatment of Glabellar Frown Lines

A Study of JR-171 in Patients With Mucopolysaccharidosis I